HealthCare Global Enterprises Limited has announced the approval of an Employee Stock Option Scheme, 2026 (HCG ESOS 2026). The Nomination and Remuneration Committee has sanctioned the grant of options to eligible employees. A total of 64,46,843 options have been granted, convertible into equity shares at an exercise price of INR 495 per share. The scheme terms are in accordance with SEBI (SBEB) Regulations, 2021.
HealthCare Global Enterprises Approves Stock Option Grant
HealthCare Global Enterprises Limited has officially announced the approval of its Employee Stock Option Scheme, 2026 (HCG ESOS 2026). This decision was made during a meeting of the Nomination and Remuneration Committee of the Board of Directors held on September 09, 2026. The committee has sanctioned the grant of Employee Stock Options (ESOPs) to eligible employees across the company and its subsidiaries and associate companies.
Scheme Details and Grant Information
Under the HCG ESOS 2026, a total of 64,46,843 (sixty-four lakhs forty-six thousand eight hundred and forty-three) options have been granted. Each option, upon exercise, will be convertible into one equity share of the company with a face value of INR 10 each, fully paid-up. The exercise price for these options has been set at INR 495 per share. The scheme is in compliance with the SEBI (SBEB) Regulations, 2021.
Vesting and Exercise Period
While the options are not yet vested at this stage, the grant specifies a vesting period determined by the Nomination and Remuneration Committee. This period will be no less than one year and no more than seven years from the grant date. The exercise period for these options is a maximum of ten years from the grant date, commencing after the expiry of six years from the grant date, or upon a change in control event, whichever occurs earlier. In the event of a change in control, grantees will have a period of six months from such event to exercise vested options, provided it occurs after the first year from the grant date.
Significant Terms
The significant terms of the HCG ESOS 2026 are consistent with those previously disclosed under the company’s postal ballot notice. Information regarding options exercised, money realized, shares arising from exercise, lapsed options, and variations in terms are not applicable at this stage, as the options have just been granted.
Source: BSE
